Abbott 2003 Global Citizenship Report - Abbott Laboratories

Index of Key Terms
A Access to medicines ..................................16-21
Accident reporting ....................................35, 40
Air emissions..............................................36, 47
Auditing ....................................................39, 47
Awards and recognition............................25, 30, 48
B Benefits ......................................................31
Board of directors ......................................11
Business association memberships ..........7, 40
Business conduct........................................9, 10-13
C Career development ..................................29-30
CEO statement ..........................................2-3
Certification ..............................................10
Charitable contributions ..........................8, 19, 26, 33, 46
Clinical research standards ......................24
Community outreach................................8, 14-15, 19-21,
26, 32-33, 42, 45
Compliance................................................10-12, 39
Conservation..............................................45
Corporate governance ..............................10-11
Corporate responsibility statements ........11, 13, 35
of conduct
D Discrimination and harassment ..............33
Diversity of suppliers ................................14
Diversity of work force ..............................29-31
E Economic performance ............................5, 46
Emergency preparedness and response ..41
Emissions, effluents and waste ................36-38, 46-47
Employee health and safety ....................40
Employee training ....................................10-13, 29, 31,
41-43
Energy consumption ................................36
Environmental impacts of products ........44
and services
Environmental liabilities ..........................44
Environmental performance ....................35-39, 46-47
Environmental policy................................35
Equal opportunity ....................................29-31
F Facilities......................................................5, 14, 42
Financial information ..............................5, 46
H Health and safety ......................................40-43
I Illness reporting ........................................40
Intellectual property..................................25
M Management systems ..............................7-8, 11, 13,
29, 35
Manufacturing locations ..........................5, 14, 42
Materials use..............................................44
O Organizational structure and ..................7, 11
responsibilities
Ozone depleting substances......................37
P Pharmaceuticals in the environment ......7
Philanthropic contributions......................8, 19-21, 26, 46
Political activity ........................................2, 8, 18
Product donations ....................................8, 19, 46
Product life cycle........................................24, 44
Products and services ................................5
Public health..............................................17-21, 23, 45
R Reporting approach and coverage ..........i, 2-3
Research and development ......................23-27
S Sales............................................................5, 46
Science education ......................................8, 26
Social performance....................................19-21, 46
Stakeholder issues......................................7
Stakeholder relationships..........................7-8, 11, 13-15,
18, 20-21, 24, 26,
28-31, 40, 42, 45
Stakeholders ..............................................7
Stock listing ................................................5
Supplier evaluations..................................13-14
T Taxes paid ..................................................46
V
Vision and strategy....................................7
W Waste generation ......................................38, 47
Wastewater discharges ..............................38, 47
Water use....................................................37
G Global Reporting Initiative ......................i
Greenhouse gas emissions ........................37, 46
Grievance system, employees ..................11
A list of awards and recognitions received by Abbott in 2003 is
available at www.abbott.com/corporate/awards.html.
forty-eight